Practice
Synthetic cannabinoids
Tony Antoniou and David N. Juurlink
CMAJ February 18, 2014 186 (3) 210; DOI: https://doi.org/10.1503/cmaj.130510
Tony Antoniou
Department of Family and Community Medicine (Antoniou), St. Michael’s Hospital; Leslie Dan Faculty of Pharmacy (Antoniou), University of Toronto; Institute for Clinical Evaluative Sciences (Juurlink); Department of Medicine (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.
PhDDavid N. Juurlink
Department of Family and Community Medicine (Antoniou), St. Michael’s Hospital; Leslie Dan Faculty of Pharmacy (Antoniou), University of Toronto; Institute for Clinical Evaluative Sciences (Juurlink); Department of Medicine (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.
MD PhD![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Online Appendix
Related Articles
- (2014). Highlights. CMAJ, 186(3), 159. Accessed August 13, 2024. Retrieved from http://www.cmaj.ca/content/186/3/159.
In this issue
Article tools
Respond to this article
Synthetic cannabinoids
Tony Antoniou, David N. Juurlink
CMAJ Feb 2014, 186 (3) 210; DOI: 10.1503/cmaj.130510
Jump to section
Related Articles
Cited By...
- No citing articles found.